LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
LBPWQ 4D PHARMA PLC C/WTS 22/03/2026 (TO PUR COM)
- 0.000001
- 0.0000000.00%
15min DelayClose Jan 27 16:00 ET
0Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.00010052wk High0.00P/B0Float Cap0.00000152wk Low--Dividend TTM0Shs Float0.040000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
4D PHARMA PLC C/WTS 22/03/2026 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.25%522K | 160.28%534K | 205.16K | 0 | 0 | 0 | 0 | |
| Operating revenue | -2.25%522K | 160.28%534K | --205.16K | --0 | ---- | --0 | --0 | --0 |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | -3.27%27.05M | -7.34%27.97M | -2.11%30.18M | 51.43%30.83M | 55.57%20.36M | 23.10%13.09M | 206.13%10.63M | 3.47M |
| Selling and administrative expenses | 23.78%7.04M | -28.18%5.69M | -11.05%7.92M | 318.26%8.9M | 10.37%2.13M | 8.38%1.93M | 104.95%1.78M | --868K |
| -General and administrative expense | 23.78%7.04M | -28.18%5.69M | -11.05%7.92M | 318.26%8.9M | 10.37%2.13M | 8.38%1.93M | 104.95%1.78M | --868K |
| Research and development costs | -10.09%19.82M | -1.01%22.04M | 1.52%22.26M | 29.69%21.93M | 65.47%16.91M | 21.87%10.22M | 360.01%8.39M | --1.82M |
| Depreciation amortization depletion | -18.37%231K | --283K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | -18.37%231K | --283K | ---- | ---- | 19.64%67K | 1,766.67%56K | -97.37%3K | --114K |
| Other operating expenses | 20.00%-36K | ---45K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 3.29%-26.53M | 8.49%-27.43M | 2.78%-29.98M | -51.43%-30.83M | -55.57%-20.36M | -23.10%-13.09M | -206.13%-10.63M | -3.47M |
| Net non-operating interest income expense | -262.50%-609K | -382.40%-168K | -79.92%59.49K | -17.46%296.32K | -38.21%359K | 28.82%581K | 418.39%451K | 87K |
| Non-operating interest income | -80.00%1K | -91.60%5K | -80.08%59.49K | -38.03%298.68K | -26.07%482K | 44.57%652K | 390.22%451K | --92K |
| Non-operating interest expense | 252.60%610K | --173K | ---- | -98.08%2.36K | 73.24%123K | --71K | --0 | --5K |
| Other net income (expense) | -1,004.00%-30.33M | -2.75M | ||||||
| Gain on sale of security | 3,775.48%14.07M | --363K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | -1,327.49%-44.4M | -237.44%-3.11M | 717.50%2.26M | 89.69%-366.46K | -177,750.00%-3.55M | 200.00%2K | -100.14%-2K | --1.39M |
| -Less：Restructuring and merger&acquisition | 1,327.04%44.38M | 237.44%3.11M | -717.50%-2.26M | -89.45%366.46K | --3.47M | --0 | ---- | ---1.39M |
| -Less:Other special charges | --14K | ---- | ---- | ---- | 4,050.00%79K | -200.00%-2K | --2K | ---- |
| -Gain on sale of property,plant,equipment | ---14K | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | 4.44%5.25M | --5.03M | ---- | ---- | ---- | ---- |
| Income before tax | -89.37%-57.47M | -31.17%-30.35M | 9.96%-23.13M | -7.11%-25.69M | -104.90%-23.99M | -16.37%-11.71M | -322.65%-10.06M | -2.38M |
| Income tax | 20.03%-3.51M | -4.38M | 0 | 0 | -92.13%-3.54M | 20.83%-1.84M | -2.33M | 0 |
| Net income | -107.83%-53.96M | -12.23%-25.96M | 9.96%-23.13M | -25.66%-25.69M | -107.29%-20.45M | -27.58%-9.86M | -224.83%-7.73M | -2.38M |
| Net income continuous Operations | -107.83%-53.96M | -12.23%-25.96M | 9.96%-23.13M | -25.66%-25.69M | -107.29%-20.45M | -27.58%-9.86M | -224.83%-7.73M | ---2.38M |
| Minority interest income | 48.75%-184K | -359K | ||||||
| Net income attributable to the parent company | -107.83%-53.96M | -12.23%-25.96M | 9.96%-23.13M | -25.66%-25.69M | -107.29%-20.45M | -30.69%-9.86M | -273.43%-7.55M | -2.02M |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -107.83%-53.96M | -12.23%-25.96M | 9.96%-23.13M | -25.66%-25.69M | -107.29%-20.45M | -30.69%-9.86M | -273.43%-7.55M | -2.02M |
| Basic earnings per share | ||||||||
| Diluted earnings per share | ||||||||
| Dividend per share | ||||||||
| Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Trending Stocks
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites